• Aging and Sex
  • For men
    • Multi Vitamin for Him CPA
    • Practical Tips to Maintain Sexual Virility
    • ProSolution Plus is a Natural Remedy For Premature Ejaculation
  • for women
    • Breast Actives CPA
    • Four Ways To Look Young
    • Ten Ways to Look Like a Model Bride
  • Home Based Business
    • AWESOME EASY CASH MONEY TO YOU TODAY!
    • Craft Idea for a Group: Make a Mural
    • DIGISOFT PAYLINE How to Make Instant Money Now DIGISOFT PAYLINE
    • Getting Your Family Involved In Your Home Business
    • Home Based Real Estate Investing
    • Home Based Real Estate Investing
    • How To Become A Work At Home Mom
    • How to Get Free Rent
    • Make Extra Cash & Work From Home!
    • Strategies for Success in the Exciting and Lucrative Home-Based Business of Jewelry & Gemstones
    • THE INTERNATIONAL PROJECT OF THE 21st CENTURY
    • WIN FREE DOGECOINS EVERY HOUR!
  • How you can Regain your Youthful Appearance without Expensive Treatments or Surgery!
  • Intelligent nutritional supplements
    • Antioxidants Nutrients Have Powerful Anti-Cancer Activity!
    • AsthmaMist CPA
    • What Are Phytoceramides?
    • Cleanse the Body, Curb Unhealthy Cravings, and Lose Weight with ProShape Rx
  • interesting idea, hobby
    • Christmas Craft: Bead and Pipe Cleaner Ornaments
    • Wedding Crafts Ideas for Saving Money
  • Natural products for weight loss
    • Natural Weight Loss Products
  • Privacy Policy
  • Terms And Conditions

Health and Beauty

The site is about the beauty and health of men, women, children

  • Home

Enter your email address:

Spam Blocked

18,994 spam blocked by Akismet

New Targets for Melanoma Treatment Identified

  • Health

Melanoma is a type of skin cancer. Once it spreads, or metastasizes, it is known as metastatic melanoma. This type of melanoma typically occurs during stage III or stage IV.

Common sites for metastases include the lymph nodes, the tissue under the skin, the lungs, the liver and the brain. Early detection is particularly important in cutaneous melanoma, the most aggressive type of skin cancer: with a thickness of little more than one millimetre, the tumour may begin to spread, sending its cells to colonise other organs.

‘Melanoma usually starts as a single lesion on the skin or mucous membranes. This lesion can progress to formation of metastases if it is not recognised and treated effectively at its early stages.’

When this occurs, the prognosis is usually poor. Treatments have improved considerably, particularly regarding immunotherapy, but melanoma mortality remains very high. One of the important questions to be answered is how melanomas acquire this inherent potential to metastasize. A technique that makes it possible to follow in vivo and, for the first time, very early stages of melanoma progression in mice, is now allowing researchers at the Spanish National Cancer Research Centre (CNIO) to study the process in detail and has even led to the identification of a potential new drug target. The paper is published in the prestigious scientific journal, Nature.

The results of the work, which has involved an international team led by the researcher Marisol Soengas at the CNIO, are doubly relevant; according to Soengas: “We have been able to discover unknown mechanisms in the development of melanoma, and to identify new markers of metastasis that we have validated in samples from patients. These results open up new avenues for pharmacological treatments.”

One of the novelties of this paper is the development of MetAlert melanoma models. The researchers have developed mouse models that can reveal, without surgery or additional interventions, how melanoma acts throughout the body, even before the occurrence of metastases. The imaging strategy is based on highly innovative work by the group headed by Sagrario Ortega at the CNIO, which used genetic modifications to obtain mice that emit light (bioluminescence) when there is a pathogenic activation of lymphatic vessels. “These bioluminescent mice are ideal for studying melanoma” indicates Ortega, “because the generation of lymphatic vessels, or lymphangiogenesis, is one of the initial steps in the dissemination of this cancer.”

The value of MetAlert lies in the fact that it guides researchers when looking for genes and molecules involved in tumour progression at the earliest stage. It also helps study relapses after surgery, or the response to anticancer drugs. To date, the techniques available for use in animals required probes or markers that had to be injected into the area around the tumour, or that were based on the detection of tumour cells once they were already present in other organs, i.e. once metastasis had begun.

As David Olmeda, lead author of the paper, says “one of the major complications in tracking melanomas has been precisely the lack of sensitivity of the standard techniques.”

NEW MECHANISMS OF METASTASIS

The paper now published in Nature details how, thanks to MetAlert, researchers have detected the mechanisms that melanomas activate very early on to create their own pathways of dissemination, in part through the lymph vessels. It has been suspected for some time that, before spreading, melanomas prepare the ground in the organs they are going to colonise. It was believed that this process involved activating the lymphatic vasculature in the tumour first and then in adjacent lymph nodes, the sentinel nodes, in order to reach more distant organs. However, removing the sentinel nodes does not prevent metastases in other organs, which indicates that something is missing in that model.

The CNIO Melanoma group has discovered what it is. Thanks to the MetAlert models, it has been possible to prove that when these tumours are aggressive, they act at a distance much earlier than previously thought, and do so without the need to resort to the proteins that were previously considered essential to activate lymphangiogenesis in the tumour. “These results indicate a change of paradigm in the study of melanoma metastasis,” says Soengas.

As a result of their observations, the group decided to get a complete map of the proteins secreted by aggressive and non-aggressive melanomas. The results were instantly clear: “We found many proteins that are secreted specifically by melanomas that act at a distance, but in this paper, we focused on one in particular, MIDKINE, because it was new and could represent an alternative therapeutic target,” explains Olmeda.

MIDKINE: A KEY TO MELANOMA METASTASIS AND A MARKER OF AGGRESSIVENESS

Once again using the MetAlert mice, the CNIO Melanoma group has shown that MIDKINE plays an essential role in metastasis, to the point that its activation determines the tumour’s ability to spread through the body. In addition, they have described an entire set of signals that mediate this process. To this end, CNIO’s Melanoma group created MetAlert avatar mice that integrate human tumour samples on their skin. They also generated other MetAlert variants that reproduce mutations that are characteristic of melanomas in humans. The project also included highly sophisticated in vivo microscopy studies carried out in collaboration with the Mount Sinai Icahn School of Medicine in New York.

Following the studies conducted on mouse models, the researchers demonstrated how important MIDKINE would be in patients with melanoma. In collaboration with dermatology and pathology experts at the Hospital 12 de Octubre in Madrid, and the Hospital Clinic in Barcelona, they analysed the expression of MIDKINE in benign lesions (moles) and in melanomas at different stages of development. This experiment demonstrated that patients with high levels of MIDKINE in their lymph nodes have a worse prognosis; a finding that will lead to the use of MIDKINE as a potential biomarker of aggressiveness.

The paper has further implications, because when MIDKINE is inhibited, metastasis is also blocked as the team discovered in animal models.

“In MIDKINE we have found a possible strategy that merits consideration for drug development”, says Soengas. “MIDKINE is not the only target, of course, but as melanoma is one of the cancers with the highest number of mutations described, finding a protein that can serve to block metastasis is an important step.”

The researchers predict that the discovery of MIDKINE is only the beginning. “These metastasis-visualisation techniques are opening up new avenues of research regarding new tumour mechanisms and other preclinical studies,” say Soengas, Ortega, and Olmeda, “and they are very useful because they can be adapted to various types of cancer, not only to melanoma.”

Source: Eurekalert

Let’s block ads! (Why?)

July 10, 2017 admin

Post navigation

Shortage of Bee, Wasp Venom Stings Those With Allergies → ← Early Detection of Cancer With the Help of 'nanolock'

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Genital Warts Natural and Alternative Treatment Remedies 1,696 views
  • ‘Love Hormone’ Oxytocin May Enhance Feelings Of Spirituality 942 views
  • WIN FREE DOGECOINS EVERY HOUR! 868 views
  • Ginseng: Root of Immortality 851 views
  • Get Rid of Cellulite, Once and For All! 700 views
  • THE INTERNATIONAL PROJECT OF THE 21st CENTURY 692 views
  • Breast Actives CPA 681 views
  • for women 660 views

Popular articles

  • Genital Warts Natural and Alternative Treatment Remedies 1,696 views | under alternative medetsina
  • ‘Love Hormone’ Oxytocin May Enhance Feelings Of Spirituality 942 views | under alternative medetsina
  • WIN FREE DOGECOINS EVERY HOUR! 868 views
  • Ginseng: Root of Immortality 851 views | under alternative medetsina
  • Get Rid of Cellulite, Once and For All! 700 views | under Body Health
  • THE INTERNATIONAL PROJECT OF THE 21st CENTURY 692 views
  • Breast Actives CPA 681 views
  • for women 660 views
Buy Brand Drugs

Archives

Powered by WordPress | theme SG Double